Compare FLNC & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLNC | AMPH |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2021 | 2005 |
| Metric | FLNC | AMPH |
|---|---|---|
| Price | $5.96 | $25.90 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 23 | 7 |
| Target Price | $8.95 | ★ $22.50 |
| AVG Volume (30 Days) | ★ 5.9M | 411.5K |
| Earning Date | 11-23-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.81 |
| Revenue | ★ $2,262,830,000.00 | $719,887,000.00 |
| Revenue This Year | $6.22 | $3.87 |
| Revenue Next Year | $27.68 | $4.90 |
| P/E Ratio | ★ N/A | $32.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.68 | $16.65 |
| 52 Week High | $33.51 | $29.52 |
| Indicator | FLNC | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 25.45 | 57.19 |
| Support Level | N/A | $25.23 |
| Resistance Level | $8.11 | $29.40 |
| Average True Range (ATR) | 0.39 | 0.83 |
| MACD | -0.03 | -0.14 |
| Stochastic Oscillator | 6.25 | 48.79 |
Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.